4.8 Article

Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy

期刊

ACS NANO
卷 16, 期 1, 页码 721-735

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsnano.1c08232

关键词

hypoxia; chemoresistance; on-site size transformation; bioorthogonal chemistry; immunogenic cell death; nitric oxide

资金

  1. National Natural Science Foundation of China [51873072, 52073101]
  2. Science and Technology Program of Guangzhou [202102010025]
  3. Guangdong Provincial Pearl River Talents Program [2019QN01Y088]
  4. Special Fund for the Construction of High-level Key Clinical Specialty (Medical Imaging) in Guangzhou
  5. Guangzhou Key Laboratory of Molecular Imaging and Clinical Translational Medicine
  6. Open Fund of Key Laboratory of Biomaterials of Guangdong Higher Education Institutes
  7. Guangdong Provincial Engineering and Technological Research Center for Drug Carrier Development

向作者/读者索取更多资源

In this study, a clustered nanosystem was designed to overcome hypoxic resistance in tumors and enhance chemoimmunotherapy. This system utilized tumor acidity-responsive groups and bioorthogonal click chemistry to form large-sized aggregates in tumor tissue, which then slowly dissociated into ultrasmall nanoparticles for enhanced drug delivery. This system not only addressed hypoxia-induced chemoresistance and enhanced antitumor immune responses but also provided a general drug delivery strategy for improved tumor accumulation and penetration.
Hypoxia, a common feature of most solid tumors, causes severe tumor resistance to chemotherapy and immunotherapy. Herein, a tumor-acidity and bioorthogonal chemistry-mediated on-site size transformation clustered nanosystem is designed to overcome hypoxic resistance and enhance chemoimmunotherapy. The nanosystem utilized the tumor-acidity responsive group poly(2-azepane ethyl methacrylate) with a rapid response rate and highly efficient bioorthogonal click chemistry to form large-sized aggregates in tumor tissue to enhance accumulation and retention. Subsequently, another tumor-acidity responsive group of the maleic acid amide with a slow response rate was cleaved allowing the aggregates to slowly dissociate into ultrasmall nanoparticles with better tumor penetration ability for the delivery of doxorubicin (DOX) and nitric oxide (NO) to a hypoxic tumor tissue. NO can reverse a hypoxia-induced DOX resistance and boost the antitumor immune response through a reprogrammed tumor immune microenvironment. This tumor-acidity and bioorthogonal chemistry-mediated on-site size transformation clustered nanosystem not only helps to counteract a hypoxia-induced chemoresistance and enhance antitumor immune responses but also provides a general drug delivery strategy for enhanced tumor accumulation and penetration.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据